Published in:
01-04-2018 | REVIEW ARTICLE
Old Drugs for New Indications in Cardiovascular Medicine
Authors:
Yaron Arbel, Wael Abuzeid, Robert S Rosenson, Alanna Weisman, Michael E. Farkouh
Published in:
Cardiovascular Drugs and Therapy
|
Issue 2/2018
Login to get access
Abstract
Inflammation participates in the initiation and progression of atherosclerotic cardiovascular disease, and it is a critical inciting factor leading to acute ischemic events. Evidence has shown that certain anti-inflammatory medications used to treat non-atherosclerotic inflammatory diseases reduce cardiovascular events. This article reviews evidence that commonly used anti-inflammatory therapies (colchicine, allopurinol, methotrexate), reduce cardiovascular events. We discuss potential mechanisms of action, efficacy, and safety of these therapies and propose a clinical trials design to investigate their efficacy.